New York State Common Retirement Fund trimmed its Regeneron stake by 5% in Q1, selling over 6,800 shares worth millions.

Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock a strong long-term opportunity.

Thomson Reuters shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 86.

Gen Digital GEN saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 68 to 74. This unique rating identifies market leadership by showing how a stock's ...

New York State Common Retirement Fund trimmed its Lockheed Martin holdings by 12% in Q1, shedding over 33,000 shares. The ...